DBV Technologies S.A. financial data

Symbol
DBVT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
107 Avenue De La Republique, Chatillon, France
State of incorporation
France
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 500 % -34.1%
Debt-to-equity 31.4 % +43%
Return On Equity -56.8 % -17.7%
Return On Assets -43.2 % -9.23%
Operating Margin -561 % +75.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.4M shares +2.43%
Entity Public Float 183M USD -43.4%
Common Stock, Value, Issued 11M USD +2.34%
Weighted Average Number of Shares Outstanding, Basic 96.2M shares +2.35%
Weighted Average Number of Shares Outstanding, Diluted 96.2M shares +2.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 14.9M USD +233%
Research and Development Expense 65.6M USD -17.3%
Selling and Marketing Expense 2.76M USD +75%
General and Administrative Expense 30.4M USD +23.7%
Operating Income (Loss) -83.8M USD +17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -79.5M USD +20.7%
Income Tax Expense (Benefit) 55K USD
Net Income (Loss) Attributable to Parent -79.5M USD +20.6%
Earnings Per Share, Basic -0.82 USD/shares +29.3%
Earnings Per Share, Diluted -0.82 USD/shares +29.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 102M USD -47.2%
Other Assets, Current 18M USD +0.51%
Assets, Current 120M USD -43.1%
Property, Plant and Equipment, Net 12.9M USD -12.7%
Operating Lease, Right-of-Use Asset 6.55M USD +208%
Intangible Assets, Net (Excluding Goodwill) 52K USD +420%
Other Assets, Noncurrent 6.82M USD +18.1%
Assets 146M USD -37.4%
Liabilities, Current 26.5M USD -19.2%
Operating Lease, Liability, Noncurrent 6.79M USD +899%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 34.2M USD -36.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 683K USD -2.15%
Retained Earnings (Accumulated Deficit) -266M USD +4.97%
Stockholders' Equity Attributable to Parent 112M USD -37.7%
Liabilities and Equity 146M USD -37.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -34.7M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -62K USD -343%
Net Cash Provided by (Used in) Investing Activities -2.13M USD -5176%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.8M USD -136%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 141M USD -32.4%
Deferred Tax Assets, Valuation Allowance 310M USD +10.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.25 pure 0%
Deferred Tax Assets, Gross 310M USD +10.3%
Operating Lease, Liability 7.03M USD +170%
Depreciation 3.6M USD +33.3%
Payments to Acquire Property, Plant, and Equipment 1.34M USD +1103%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.5M USD +21.7%
Lessee, Operating Lease, Liability, to be Paid 1.79M USD
Property, Plant and Equipment, Gross 31.6M USD +5.67%
Operating Lease, Liability, Current 232K USD -87.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 127K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.67M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.91M USD +748%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 307M USD +12.2%
Operating Lease, Payments 501K USD +1.01%
Additional Paid in Capital 379M USD -17.5%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense -6.35M USD -19.8%